Brandywine Oak Private Wealth’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,333
| Closed | -$290K | – | 306 |
|
|
2022
Q2 | $290K | Buy |
5,333
+2
| +0% | +$109 | 0.04% | 252 |
|
|
2022
Q1 | $290K | Buy |
5,331
+1
| +0% | +$54 | 0.03% | 263 |
|
|
2021
Q4 | $293K | Buy |
5,330
+480
| +10% | +$26.4K | 0.03% | 253 |
|
|
2021
Q3 | $231K | Buy |
+4,850
| New | +$231K | 0.03% | 306 |
|
|
2020
Q4 | – | Sell |
-5,134
| Closed | -$241K | – | 271 |
|
|
2020
Q3 | $241K | Hold |
5,134
| – | – | 0.04% | 222 |
|
|
2020
Q2 | $261K | Buy |
5,134
+1
| +0% | +$51 | 0.05% | 189 |
|
|
2020
Q1 | $243K | Buy |
5,133
+105
| +2% | +$4.97K | 0.05% | 190 |
|
|
2019
Q4 | $295K | Buy |
5,028
+314
| +7% | +$18.4K | 0.05% | 181 |
|
|
2019
Q3 | $251K | Buy |
+4,714
| New | +$251K | 0.05% | 196 |
|
|
2019
Q1 | – | Sell |
-716
| Closed | -$34K | – | 376 |
|
|
2018
Q4 | $34K | Buy |
+716
| New | +$34K | 0.01% | 404 |
|